Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genomics, |
RCV003224396 | SCV003919777 | uncertain significance | Susceptibility to HIV infection; Mycobacterium tuberculosis, susceptibility to; Dengue virus, susceptibility to | 2021-03-30 | criteria provided, single submitter | clinical testing | CD209 NM_021155.3 exon 4 p.Glu214Asp (c.642G>C):This variant has not been reported in the literature but is present in 0.5% (59/11200) of African alleles, including 1 homozygote in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs11465377). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Breakthrough Genomics, |
RCV004692222 | SCV005192539 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003918251 | SCV004736633 | benign | CD209-related disorder | 2019-10-31 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |